Appendiceal Neuroendocrine Tumours

Appendiceal neuroendocrine tumours (NETs), also known as appendiceal carcinoid tumours, are a rare form of cancer that develop in the appendix, a small, finger-shaped pouch connected to the caecum of the large bowel/intestine.  It sits on the lower right side of the abdomen, and has an unknown function within the body.

Neuroendocrine cancers are a complex group of tumours that develop in the neuroendocrine system, which is responsible for regulating important bodily functions such as heart rate, blood pressure and metabolism. They most commonly develop in the gastro-intestinal tract, pancreas, and the lungs; however, they can develop anywhere in the body. These tumours develop from neuroendocrine cells, which are responsible for receiving signals from the nervous system and producing hormones and peptides (small proteins) in response.

Appendiceal NETs generally affect the production of enterochromaffin cells, which can produce a variety of hormones – most commonly serotonin. Serotonin is a neurotransmitter that plays a crucial role in a variety of bodily functions, such as digestion and the regulation of mood, appetite and sleep.

Appendiceal NETs are slightly more common in females, and tend to be diagnosed before the age of 40. However, anyone can develop this disease.

Types of Appendiceal Neuroendocrine Tumours

Because of how rare appendiceal NETs are, there has been limited research done into the subtypes of this disease. However, one distinct variant has been identified.

Goblet Cell Carcinoma (GCC)

Goblet cell carcinomas (GCC) are rare neuroendocrine tumours that develop from goblet cells in the appendix, which are responsible for mucus secretion and production.

GCCs demonstrate a unique combination of both neuroendocrine cells and adenocarcinoma cells, which are cancerous cells that develop from mucus-producing cells. They tend to be more aggressive than classic neuroendocrine tumours, but are classified and staged as carcinomas of the appendix.

For more information on GCCs, please refer to the Rare Cancers Australia Goblet Cell Carcinoma (GCC) page.

Treatment

If an appendiceal NET is detected, it will be staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you.

Cancers can be staged using the TNM staging system:

  • T (tumour) indicates the size and depth of the tumour.
  • N (node) indicates whether the cancer has spread to nearby lymph nodes.
  • M (metastasis) indicates whether the cancer has spread to other parts of the body.

This system can also be used in combination with a numerical value, from stage 0-IV:

  • Stage 0: this stage describes cancer cells in the place of origin (or ‘in situ’) that have not spread to nearby tissue.
  • Stage I: cancer cells have begun to spread to nearby tissue. It is not deeply embedded into nearby tissue and had not spread to lymph nodes. This stage is also known as early-stage cancer.
  • Stage II: cancer cells have grown deeper into nearby tissue. Lymph nodes may or may not be affected. This is also known as localised cancer.
  • Stage III: the cancer has become larger and has grown deeper into nearby tissue. Lymph nodes are generally affected at this stage. This is also known as localised cancer.
  • Stage IV: the cancer has spread to other tissues and organs in the body. This is also known as advanced or metastatic cancer.

Cancers can also be graded based on the rate of growth and how likely they are to spread:

  • Grade I: cancer cells present as slightly abnormal and are usually slow growing. This is also known as a low-grade tumour.
  • Grade II: cancer cells present as abnormal and grow faster than grade-I tumours. This is also known as an intermediate-grade tumour.
  • Grade III: cancer cells present as very abnormal and grow quickly. This is also known as a high-grade tumour.

Once your tumour has been staged and graded, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. This is often performed after a biopsy, and can help guide treatment options for you.

 

Treatment is dependent on several factors, including location, stage of disease and overall health.

 

Treatment options for appendiceal NETs may include:

  • Surgery, potentially including:
    • Appendectomy.
    • Right hemicolectomy (for tumours larger than 2cm).
    • Liver resection (for metastatic disease, very rare).
  • Somatostatin analogues (SSAs) (for metastatic disease, very rare).
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare appendiceal NETs are, there has been limited research done into the risk factors of this disease.

Symptoms

Most patients with appendiceal NETs appear asymptomatic, and the tumours are often found incidentally. As the tumour progresses, some of the following symptoms may appear:

  • Abdominal pain in the lower right quadrant (often caused by an appendicitis).
  • Gradual increase in waist size.
  • Ascites.
  • Bloating.
  • Changes in bowel habits, potentially including constipation or diarrhea.
  • Hernia.
  • Ovarian mass/lump.
  • Nausea and/or vomiting.
  • Feeling full after eating little food.
  • Carcinoid syndrome, which carries its own set of symptoms:
    • Facial flushing (usually red or purple in the face, neck, and/or upper chest).
    • Diarrhoea.
    • Wheezing.
    • Abdominal pain.
    • Carcinoid heart disease (plaques on the heart muscle caused by excess hormone production).
    • Faecal urgency.
    • Fatigue.
    • Skin changes, such as red or purple spots on the face, neck, and/or upper chest.
  • Bowel obstruction.
  • Abdominal lumps.
  • Gastrointestinal bleeding.
  • Intussusception.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

Most appendiceal NETs are found incidentally when being treated for another condition, such as an appendicitis. If your doctor suspects you have an appendiceal NET, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
    • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
    • Ultrasound.
  • Blood tests.
  • Diagnostic laparoscopy.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.